Cathie Wood Crispr Therapeutics Ag Transaction History
Ark Investment Management LLC
- $10.5 Billion
- Q3 2024
A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Ark Investment Management LLC holds 7,498,625 shares of CRSP stock, worth $354 Million. This represents 3.35% of its overall portfolio holdings.
Number of Shares
7,498,625
Previous 7,778,536
3.6%
Holding current value
$354 Million
Previous $420 Million
16.13%
% of portfolio
3.35%
Previous 3.82%
Shares
30 transactions
Others Institutions Holding CRSP
# of Institutions
491Shares Held
58MCall Options Held
1.1MPut Options Held
1.9M-
Capital International Investors Los Angeles, CA7.93MShares$375 Million0.07% of portfolio
-
State Street Corp Boston, MA2.99MShares$141 Million0.01% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.97MShares$140 Million0.1% of portfolio
-
Nikko Asset Management Americas, Inc.2.97MShares$140 Million1.61% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$131 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.69B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....